Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZYMEWORKS INC (US)

13.35
+0.01000.07%
Post-market: 13.09-0.2600-1.95%17:24 EDT
Volume:355.29K
Turnover:4.75M
Market Cap:999.17M
PE:-8.88
High:13.60
Open:13.28
Low:13.24
Close:13.34
Loading ...

Zymeworks Inc. Unveils Presentation on Advancements in Targeted Therapies for Cancer and Autoimmune Diseases

Reuters
·
08 Jul

Zymeworks Price Target Maintained With a $13.00/Share by HC Wainwright & Co.

Dow Jones
·
03 Jul

Zymeworks Inc. Amends Pre-Funded Warrants and Purchasers Net Exercise Warrants for 5.1 Million Shares

Reuters
·
28 Jun

BRIEF-Zymeworks' Zanidatamab Approved in China for HER2-High Expression Biliary Tract Cancer

Reuters
·
30 May

Zymeworks Inc. Secures NMPA Approval for Zanidatamab in China, Set to Receive $20 Million Milestone Payment from BeOne Medicines

Reuters
·
30 May

Zymeworks Announces Nmpa Approval of Zanidatamab in China for Adults With Previously Treated, Unresectable or Metastatic Her2-High Expression (Ihc3+) Biliary Tract Cancer

THOMSON REUTERS
·
30 May

Zymeworks Inc - Zym Works to Receive $20 Mln Milestone Payment From Beone Medicines

THOMSON REUTERS
·
30 May

Zymeworks Inc - Zym Works Eligible for up to 19.5% Royalties on Net Sales

THOMSON REUTERS
·
30 May

Zymeworks Inc. to Present Oncology Portfolio at Upcoming ASCO Annual Meeting

Reuters
·
23 May

Zymeworks Inc. to Participate in Goldman Sachs Global Healthcare Conference

Reuters
·
21 May

Zymeworks Initiated at Buy by TD Securities

Dow Jones
·
20 May

Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday

MT Newswires Live
·
20 May

TD Cowen Initiates Coverage on Zymeworks With Buy Rating

MT Newswires Live
·
20 May

Zymeworks Inc : TD Cowen Initiates Coverage With Buy Rating

THOMSON REUTERS
·
20 May

Zymeworks: Buy Rating Driven by Innovative Pipeline and Strategic Partnerships

TIPRANKS
·
20 May

Zymeworks initiated with a Buy at TD Cowen

TIPRANKS
·
20 May

EcoR1 Capital Reports Acquisition of Common Shares in Zymeworks Inc

Reuters
·
20 May

Zymeworks Shows Positive Preclinical Data for Experimental Respiratory Imflammation Treatment

MT Newswires Live
·
20 May

Zymeworks presents new ZW1528 data at ATS conference

TIPRANKS
·
20 May

Zymeworks Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May